TrialThe Kaohsiung journal of medical sciences2017

Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease.

Satoshi Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.